Cedar Knolls, NJ (PRWEB) May 24, 2012
Xybion Corporation and QPS LLC announced today that QPS Taiwan, a global preclinical toxicology services provider, has selected to deploy Pristima®Suite, Xybion’s premier preclinical application. QPS will leverage Pristima Suite in a ‘Software as a Service’ (SaaS) deployment model, supported by Xybion’s Singapore data center & technology services group.
Pristima is an end-to-end preclinical data management system that helps companies to reduce their preclinical operational costs while decreasing time-to-market for drug discovery. QPS will be leveraging many key components of the preclinical software suite including the General Toxicology, Clinical Pathology, Necropsy, Pathology and SEND modules to capture, manage and report data from preclinical studies. Following an exhaustive selection process where all competitive products were considered, QPS Taiwan selected Pristima as a SaaS installation. Xybion will host the application in its Singapore data center. With the addition of QPS Taiwan, Xybion continues to expand its offerings in the Asia Pacific market, growing its client base to a total of 11 countries in North America, Europe and Asia. QPS Taiwan will be using the Pristima functionality to refine and expand its comprehensive GLP CRO preclinical study service capabilities to serve its clients worldwide.
Carlos Frade, Vice President of Preclinical R&D Solutions at Xybion, was quoted: “QPS Taiwan selected the Software as a service model, which offers a less time consuming validation process and a more cost effective approach to achieve the required capabilities, maintenance, and support over the Internet. QPS Taiwan will leverage Xybion’s Total Preclinical Solutions package to install, validate and deploy the most modern and most well-integrated data management suite on the market.”
Walter Bee, Ph.D., Vice President, Head of Global Safety Assessment and Regulatory Affairs, commented: “QPS Taiwan’s Center of Toxicology and Preclinical Sciences (CTPS) is one of the oldest and most experienced GLP laboratories in Asia. Our scientists combine training and experience from Europe, Japan, the USA and Asia in the unique environment of a first class Taiwanese laboratory. With the introduction of Pristima® as our data acquisition and management system, we are underlining our commitment to excellent service to our sponsors. This software enables our scientists to provide results quickly, reduces paperwork and increases data quality. It supports the organization, structure, and format of datasets in the Standard for Exchange of Non-Clinical Data (SEND) format for submission to the US Food and Drug Administration (FDA). The tailored solution Xybion provided fits our current needs but leaves room for expansion in line with our growth ambitions.”
As an enterprise-grade solution suite for preclinical research, Pristima offers a powerful and robust toolset to improve clients’ efficiency, promote compliance and accelerate the final reporting. Dr. Pradip Banerjee, CEO, Xybion Corporation commented, “We are pleased to have QPS Taiwan as a client and look forward to assisting them in reaching their business goals. We are delighted that QPS Taiwan has decided to have Xybion host Pristima in our data center. Many of our clients find SaaS delivery to be an efficient, scalable and cost effective alternative to an onsite installation. We are committed to maintaining Pristima as the leading preclinical data management solution to meet the needs of a fast growing CRO.”
About Xybion Corporation:
Xybion Corporation is a global leader in the development and delivery of critical enterprise solutions to highly regulated industries, helping companies lower cost, mitigate risk and accelerate growth, while managing quality and compliance. Xybion is the maker of Pristima Suite, a leading preclinical data management solution for the life science sector. Pristima Suite is the only fully integrated preclinical and vivarium management solution that natively connects to enterprise quality & compliance management processes on the market today.
Founded in 1995, QPS is a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development. We provide quality services to pharmaceutical and biotechnology clients worldwide. QPS operates regional laboratories and testing facilities which are located at its headquarters in Newark, DE, USA; Springfield, MO, USA; Groningen, The Netherlands; Hyderabad, India; and Taipei, Taiwan.